Sign in
Taking people in NetherlandsPhase 4

Scans lung fibroblast activity in people with long-term symptoms after COVID-19

Tests a PET scan of lung activity in adults with lingering COVID-19 breathlessness.

Key facts

Who runs it
Universitair Medisch Centrum Groningen
Where
Groningen, NetherlandsSee the site
Registry title
[68Ga]FAPI PET/CT to detect fibroblast activity in pulmonary COVID patients with and without long-term health problems.
Status
Recruiting
Phase
Phase 4
People taking part
60 people, planned
Started
1 Jul 2025
Planned end
1 Jan 2026
Type of study
Interventional
Record updated
22 September 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who had COVID-19 and still have breathlessness or fatigue, and adults whose complaints went away. A special scan is used.

Age
Adults older than 20 years (the registry also lists a minimum age of 18 years).
Sex
All sexes can join.
Disease stage
Breathlessness or fatigue for more than 3 months after a confirmed SARS-CoV-2 infection. Group 1: Fatigue Severity Scale 4 or higher. Group 2: Fatigue Severity Scale below 4, after a previous score of 4 or higher.
Biomarker or test result
SARS-CoV-2 infection confirmed by PCR, a serology test, or a CO-RADS score of 4/5.

Main reasons for not taking part

  • Cannot or will not give informed consent
  • History of claustrophobia
  • Cannot tolerate lying on the back for the PET/CT scans

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Adult patients > 20 years
  • Self-reported complaints of dyspnea or fatigue > 3 months after SARS-CoV-2 infection confirmed with PCR, serology test or COVID-19 Reporting and Data System (CO-RADS) score 4/5
  • Group 1: Fatigue Severity Scale ≥ 4 at time of [68Ga]FAPI PET/CT
  • Group 2: Fatigue Severity Scale < 4 at time of [68Ga]FAPI PET/CT after having previously recorded score of ≥ 4 or equivalent
  • In addition, when insufficient when insufficient subjects can be included in group 2 ‘Healthy’ controls will be included from the Lifelines or PARASOL cohort with the following criteria: Patients without self-reported complaints and past SARS-CoV-2 infection (which would have resulted in a Fatigue Severity Scale < 4) or without experienced confirmed SARS-CoV-2 infection

Who cannot take part

  • History of claustrophobia or feeling of inability to tolerate supine position for the PET/CT scans
  • Inability or unwilling to give informed consent

Where in Netherlands

  • University Medical Center GroningenGroningen, NetherlandsTaking people

About the trial

What the trial wants to find out

To assess if pulmonary fibroblast activity, measured by [68Ga]FAPI-PET/CT, is higher in patients with current long COVID dyspnea and fatigue compared to patients with resolved complaints.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Official title
LIBERATE; From Inflammation Biomarkers to Remodelling (FAPI PET/CT) towards personalized diagnosis in post-acute sequelae of COVID-19
Plain-language title
Scans lung fibroblast activity in people with long-term symptoms after COVID-19Generated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Record updated
22 September 2025